Botanical species · safety record

Melaleuca viridiflora

The EFSA Compendium of Botanicals holds 9 constituent measurements for Melaleuca viridiflora. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Melaleuca viridiflora Sol. ex Gaertn.

9Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Leaves	Essential oil	61.7 Percent	GC-MS	Resolve DOI
1,8-cineole	Unspecified	Essential oil	45.6 Percent	Unspecified	No resolvable identifier
1,8-cineole	Leaves	—	40.8 Percent	GC-MS	No resolvable identifier
1,8-cineole	Leaves	Essential oil	67 Percent	Gaschromatography (GC)	No resolvable identifier
1,8-cineole	—	Essential oil	≤ 70.4 Percent	GC-MS	No resolvable identifier
1,8-cineole	—	Essential oil	≥ 53 Percent	GC-MS	No resolvable identifier
Eugenol	Leaves	Solvent extraction	1 Percent	GC-MS	No resolvable identifier
Myrcene	Leaves	Essential oil	1 Percent	Gaschromatography (GC)	No resolvable identifier
Myrcene	—	Essential oil	≤ 0.6 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

De Medici, D., Pieretti, S., Salvatore, G., Nicoletti, M., Rasoanaivo, P. Chemical analysis of essential oils of Malagasy medicinal plants by gas chromatography and NMR spectroscopy. Flavour and Fragrance Journal, 1992, p. 275-281.
Jones, T. G. H., Haenke, W. L. Essential oils from the Queensland flora. XI. Melaleuca viridiflora. 2. Proc. roy. soc. queensland, 1938, p. 95-98.
Chebli, B., Hmamouchi, M., Achouri, M., Hassani, L. M. Idrissi. Composition and in vitro fungitoxic activity of 19 essential oils against two post-harvest pathogens. Journal of Essential Oil Research, 2004, p. 507-511.
Monti, D., Tampucci, S., Chetoni, P., Burgalassi, S., Bertoli, A., Pistelli, L. Niaouli oils from different sources: Analysis and influence on cutaneous permeation of estradiol in vitro. Drug delivery, 2009, p. 237-242.
Standen, M.D., Connellan, P.A., Leach, D.N. Natural killer cell activity and lymphocyte activation: Investigating the effects of a selection of essential oils and components in vitro. International journal of aromatherapy, 2006, vol. 16, no. 3-4, p. 133-139. DOI
HELLYER, RO., LASSAK, EV. STEAM-VOLATILE CONSTITUENTS OF MELALEUCA VIRIDIFLORA SOL EX GAERTN. AUSTRALIAN JOURNAL OF CHEMISTRY, 1968, vol. 21, no. 10, p. 2585-&.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature